Gefitinib plus chemotherapy versus placebo plus chemotherapy in EGFR-mutation-positive non-small-cell lung cancer after progression on first-line gefitinib (IMPRESS) a phase 3 randomised trial
本文档由 dc8vbm789 分享于2016-06-22 13:21
Gefitinib plus chemotherapy versus placebo plus chemotherapy in EGFR-mutation-positive non-small-cell lung cancer after progression on first-line gefitinib (IMPRESS) a phase 3 randomised trial
下载文档
收藏
打印
君，已阅读到文档的结尾了呢~~